But last year, the weight-loss drug Wegovy ... of other drugs among those patients fell by about 3%. Those who received the drugs were just a small fraction of young people who struggle with ...

But last year, the weight-loss ... in the use of powerful medications to treat diabetes and obesity in adolescents and young adults. Credit: AP/Mike Stewart Those who received the drugs were ...

The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared ... by the end of 2023. Among adolescents, the rate of use rose six-fold among ...

But last year, the weight-loss drug Wegovy ... prescriptions of other drugs among those patients fell by about 3%. Those who received the drugs were just a fraction of young people who struggle ...

But last year, the weight-loss drug Wegovy helped ... It's important to understand the surging use of these medications in young people, Lee said. The drugs are meant for continuing use, so ...

Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults. Skip to main content Skip to main content Register for ...

Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults. Use of weight-loss drugs soars among kids, young adults ...

In 2023, the weight-loss ... drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared nearly 600% between 2020 and 2023 in people under 25 – and ...